Wednesday, January 19, 2022

Infinity Pharmaceuticals Inc. (INFI) stock plunged following the investor event happening today

Infinity Pharmaceuticals Inc. (NASDAQ: INFI) stock declined by 2.52% at the last close whereas the INFI stock price declined by 0.43% today. Infinity Pharmaceuticals is a medical biotechnology business working on eganelisib (IPI-549) which is an oral immuno-oncology macrophage reprogramming therapy that has been shown to target a core biologic mechanism of immune suppression in cancer in several clinical trials.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


INFI stock’ Update

In the San Antonio Breast Cancer Symposium (SABCS 2021), the company will host an investor event on new data from the current MARIO-3 clinical study at 9:30 a.m. ET today.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


Hatem Soliman, MD, MARIO-3 Investigator, and Medical Director, Clinical Trials Office at the Moffitt Cancer Center, will provide a presentation during the webinar.

Dr. Soliman will speak about the changing therapy landscape for TNBC, as well as the substantial unfulfilled need for individuals with frontline, metastatic TNBC. Dr. Soliman will examine the MARIO-3 trial design and outline patient data and baseline features, as well as the MARIO-3 study’s revised safety and efficacy findings. Dr. Robert Ilaria, Infinity’s Chief Medical Officer, will discuss eganelisib’s mode of action and translational findings from the MARIO-3 research.

Furthermore,

Hatem Soliman is one of the top doctors for breast cancer in the country also he is the researcher on the MARIO-3 trial. Dr. Soliman is the Medical Director of the Moffitt Cancer Center’s Clinical Trials Office. Since joining the faculty at Moffitt in 2008, he has vast expertise as a clinical investigator undertaking both translational research in breast cancer immunotherapy and leading multiple clinical trials as a primary investigator.

This current development could be the reason behind the surge in INFI stock price during pre-market. The stockholders must be looking forward to the new findings obtained MARIO-3 clinical study which will be presented today.

Latest news

Looking Under The Hood: What’s Happening To Bee Vectoring Technologies (BEVVF) Stock

Bee Vectoring Technologies International Inc (BEVVF) closed up 24.71 percent on Wednesday at $0.3280, and has been trading in a day range of $0.2721...

Best cannabis stock investment could lead to great profits in the near future

In recent months, there has been much debate about which are the best cannabis stocks. There are several states where recreational marijuana is legal,...

Stealth BioTherapeutics Inc. (MITO) stock rose during after-hours, provided no current update.

Stealth BioTherapeutics Inc. (NASDAQ: MITO) stock plunged by 3.57% at last close whereas the MITO stock price gains by 6.17% in the after-hour trading...

CNFinance Holdings Ltd. (CNF) stock fell during after-hours, despite any current update.

CNFinance Holdings Ltd. (NASDAQ: CNF) stock declined by 20.27% in the after-hours trading session. CNFinance Holdings Limited is a significant provider of home equity...

Related news

Looking Under The Hood: What’s Happening To Bee Vectoring Technologies (BEVVF) Stock

Bee Vectoring Technologies International Inc (BEVVF) closed up 24.71 percent on Wednesday at $0.3280, and has been trading in a day range of $0.2721...

Best cannabis stock investment could lead to great profits in the near future

In recent months, there has been much debate about which are the best cannabis stocks. There are several states where recreational marijuana is legal,...

Stealth BioTherapeutics Inc. (MITO) stock rose during after-hours, provided no current update.

Stealth BioTherapeutics Inc. (NASDAQ: MITO) stock plunged by 3.57% at last close whereas the MITO stock price gains by 6.17% in the after-hour trading...

CNFinance Holdings Ltd. (CNF) stock fell during after-hours, despite any current update.

CNFinance Holdings Ltd. (NASDAQ: CNF) stock declined by 20.27% in the after-hours trading session. CNFinance Holdings Limited is a significant provider of home equity...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

1745

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam